PRLD Return on Tangible Equity | PRELUDE THERAPEUTICS INC

PRELUDE THERAPEUTICS INC (PRLD) Return on Tangible Equity

2026-06-30: Return Tang Equity -45.23%.
2026-03-31: Return Tang Equity -129.27%.
2025-12-31: Return Tang Equity -144.96%.
2025-09-30: Return Tang Equity -190.95%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-45.23%
2026-03-31	-129.27%
2025-12-31	-144.96%
2025-09-30	-190.95%
2025-06-30	-163.93%
2025-03-31	-123.89%
2024-12-31	-96.74%
2024-09-30	-84.07%
2024-06-30	-71.24%
2024-03-31	-59.58%
2023-12-31	-51.39%
2023-09-30	-49.27%
2023-06-30	-44.55%
2023-03-31	-64.86%
2022-12-31	-59.07%
2022-09-30	-55.03%
2022-06-30	-49.98%
2022-03-31	-45.78%
2021-12-31	-39.07%
2021-09-30	-31.52%
2021-06-30	-25.17%
2021-03-31	-19.27%
2020-12-31	-26.83%
2020-09-30	-20.90%
2020-06-30	54.38%
2020-03-31	54.37%
2019-12-31	55.80%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-144.96%
2024-12-31	-96.74%
2023-12-31	-51.39%
2022-12-31	-59.07%
2021-12-31	-39.07%
2020-12-31	-26.83%
2019-12-31	55.80%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
BridgeBio Oncology Therapeutics, Inc. (BBOT)	United States	$0.320B	-3.35
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58
BioAge Labs, Inc. (BIOA)	United States	$0.333B	-11.88
Vanda Pharmaceuticals Inc. (VNDA)	United States	$0.302B	-1.35
Benitec Biopharma Inc. (BNTC)	United States	$0.337B	-10.08
STANDARD BIOTOOLS INC. (LAB)	United States	$0.297B	3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)	United States	$0.296B	-21.78
Larimar Therapeutics, Inc. (LRMR)	United States	$0.344B	-1.83